Characteristics and cardiovascular disease event rates among African Americans and whites who meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) trial inclusion criteria

PURPOSE: Determine the risk for cardiovascular disease (CVD) events among adults with clinically evident CVD who meet the inclusion criteria for the FOURIER clinical trial on PCSK9 inhibition in a real-world database. METHODS: We analyzed data from 2,072 African-American and 2,972 white REasons for...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cardiovasc Drugs Ther
Hlavní autoři: Colantonio, Lisandro D., Monda, Keri L., Rosenson, Robert S., Brown, Todd M., Mues, Katherine E., Howard, George, Safford, Monika M., Yedigarova, Larisa, Farkouh, Michael E., Muntner, Paul
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6917479/
https://ncbi.nlm.nih.gov/pubmed/30746585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-019-06864-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky